MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 112 filers reported holding MEI PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $31,000 | -93.0% | 50,519 | -93.1% | 0.00% | – |
| Q1 2022 | $443,000 | -75.9% | 734,296 | +6.8% | 0.00% | -100.0% |
| Q4 2021 | $1,836,000 | -16.3% | 687,290 | -13.5% | 0.00% | 0.0% |
| Q3 2021 | $2,193,000 | -0.8% | 794,442 | +2.4% | 0.00% | 0.0% |
| Q2 2021 | $2,211,000 | -17.9% | 775,628 | -1.2% | 0.00% | 0.0% |
| Q1 2021 | $2,694,000 | +31.4% | 785,265 | +1.1% | 0.00% | 0.0% |
| Q4 2020 | $2,051,000 | +2.2% | 776,706 | +20.8% | 0.00% | 0.0% |
| Q3 2020 | $2,007,000 | +90.6% | 643,096 | +152.3% | 0.00% | 0.0% |
| Q2 2020 | $1,053,000 | +183.1% | 254,901 | +10.3% | 0.00% | – |
| Q1 2020 | $372,000 | -11.8% | 231,081 | +35.9% | 0.00% | – |
| Q4 2019 | $422,000 | +59.8% | 170,019 | +8.4% | 0.00% | – |
| Q3 2019 | $264,000 | -32.8% | 156,907 | 0.0% | 0.00% | – |
| Q2 2019 | $393,000 | +736.2% | 156,907 | +930.4% | 0.00% | – |
| Q1 2019 | $47,000 | -69.3% | 15,228 | +11.2% | 0.00% | – |
| Q1 2014 | $153,000 | +39.1% | 13,700 | 0.0% | 0.00% | – |
| Q4 2013 | $110,000 | -23.6% | 13,700 | 0.0% | 0.00% | – |
| Q3 2013 | $144,000 | +46.9% | 13,700 | 0.0% | 0.00% | – |
| Q2 2013 | $98,000 | – | 13,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|